258 related articles for article (PubMed ID: 26072728)
21. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
van Leeuwen FE; Ng AK
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
[TBL] [Abstract][Full Text] [Related]
22. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
23. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
24. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.
Chamie K; Kurzrock EA; Evans CP; Litwin MS; Koppie TM; Wootton-Gorges SL; Boone JM; Lara PN; Devere White RW
Cancer; 2011 Sep; 117(18):4219-30. PubMed ID: 21412759
[TBL] [Abstract][Full Text] [Related]
25. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
van Leeuwen FE; Stiggelbout AM; van den Belt-Dusebout AW; Noyon R; Eliel MR; van Kerkhoff EH; Delemarre JF; Somers R
J Clin Oncol; 1993 Mar; 11(3):415-24. PubMed ID: 8445415
[TBL] [Abstract][Full Text] [Related]
26. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
27. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
[TBL] [Abstract][Full Text] [Related]
28. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
29. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
30. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.
Christensen JF; Bandak M; Campbell A; Jones LW; Højman P
Acta Oncol; 2015 May; 54(5):592-9. PubMed ID: 25751759
[TBL] [Abstract][Full Text] [Related]
31. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
32. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
33. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
34. Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors.
Abou-Antoun T; Mikhael R; Massoud M; Chahine G; Saad A
Asian Pac J Cancer Prev; 2016; 17(2):749-54. PubMed ID: 26925674
[TBL] [Abstract][Full Text] [Related]
35. Treatment-associated leukemia following testicular cancer.
Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
[TBL] [Abstract][Full Text] [Related]
36. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
37. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.
Bhatia S
Cancer; 2015 Mar; 121(5):648-63. PubMed ID: 25355167
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
40. Second neoplasms after megavoltage radiation for pediatric tumors.
Gold DG; Neglia JP; Dusenbery KE
Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
